Twelve Bio was acquired by Ensoma in February 2023. Ensoma is based out of Boston, MA, with a research facility and office in Copenhagen, Denmark. We are integrating Twelve Bio’s proprietary gene editing technology into Ensoma’s Engenious™ platform to move closer to our goal of developing one-time in vivo treatments that can precisely engineer specific cells to cure diseases from within. Learn more at www.ensoma.com.
Company Details
- Address
- Copenhagen, Zealand 2200, Dk
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.ensoma.com
- HQ
- Copenhagen, Zealand
Twelve Bio Questions
Twelve Bio's website is http://www.ensoma.com
Twelve Bio's LinkedIn profile is https://dk.linkedin.com/company/twelvebio
Twelve Bio's industry is
Biotechnology Research
Twelve Bio's top competitors are
Biosyntia,
Evodiabio,
Ensoma,
Nordic Microbes,
Bioinnovation Institute,
Bactolife,
Cysbio,
Octarine Bio,
Again,
Orna Therapeutics.
Twelve Bio's categories are Biotechnology Research
